Low Doses of High-Potency Antithymocyte Globulin (ATG) in Severe Aplastic Anemia: Experience with the Mexican ATG | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Low Doses of High-Potency Antithymocyte Globulin (ATG) in Severe Aplastic Anemia: Experience with the Mexican ATG

Acta Haematol (1989) 81 (2): 70–74.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Antibodies in the Treatment of Aplastic Anemia

David Gómez-Almaguer
Jose Carlos Jaime-Pérez
Guillermo J. Ruiz-Arguelles

Archivum Immunologiae et Therapiae Experimentalis (2012) 60 (2): 99.

Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria

Guillermo J. Ruiz-Delgado
Eduardo Vázquez-Garza
Nereida Méndez-Ramírez
David Gómez-Almaguer

Hematology (2009) 14 (1): 33.

Haematopoietic stem cell transplantation to treat aplastic anaemia

Jose C Jaime-Perez
Guillermo J Ruiz-Arguelles
David Gomez-Almaguer

Expert Opinion on Biological Therapy (2005) 5 (5): 617.

More on Geographic Hematology: The Breakpoint Cluster Regions of the PML/RARα Fusion Gene in Mexican Mestizo Patients with Promyelocytic Leukemia are Different from Those in Caucasians

Guillermo J Ruiz-Argüelles
Javier Garcés-Eisele
Virginia Reyes-Núñez
José David Gómez-Rangel
Guillermo J Ruiz-Delgado

Leukemia & Lymphoma (2004) 45 (7): 1365.

The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients

David Gómez-Almaguer

International Journal of Hematology (2002) 76 (S1): 380.

Immunosuppressive Treatment of Acquired Aplastic Anemia and Immune-Mediated Bone Marrow Failure Syndromes

Neal S. Young

International Journal of Hematology (2002) 75 (2): 129.